Zachary Rovinsky signed an employment agreement as chief financial officer, and the agreements of Helena Santos and John A. Moore were extended through September 30, 2027.
Latest SCIENTIFIC INDUSTRIES INC news
We have not published a story on SCIENTIFIC INDUSTRIES INC yet. When there is news, it will appear here.
Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $616,500, plus short-term investments of $3.9 million, $4.5 million in all.
Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.
Questions about SCIENTIFIC INDUSTRIES INC
What is the ticker symbol of SCIENTIFIC INDUSTRIES INC?
SCIENTIFIC INDUSTRIES INC trades under the ticker SCND on OTC.
Where is SCIENTIFIC INDUSTRIES INC listed?
SCIENTIFIC INDUSTRIES INC is listed on OTC.
Which country or territory is SCIENTIFIC INDUSTRIES INC listed under?
Our directory records SCIENTIFIC INDUSTRIES INC under United States.
Does aibio.space cover SCIENTIFIC INDUSTRIES INC?
aibio.space lists SCIENTIFIC INDUSTRIES INC among 2,820 public biotech companies and publishes its news here as stories appear.
What was SCIENTIFIC INDUSTRIES INC's revenue last year?
$5.1 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is SCIENTIFIC INDUSTRIES INC profitable?
SCIENTIFIC INDUSTRIES INC reported a net loss of $1.2 million for the fiscal year ended Dec 31, 2025, per its annual report to the SEC.
How much does SCIENTIFIC INDUSTRIES INC spend on research and development?
$2.5 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does SCIENTIFIC INDUSTRIES INC have?
$4.5 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
What is the latest SCIENTIFIC INDUSTRIES INC (SCND) stock news?
Our latest story on SCIENTIFIC INDUSTRIES INC, dated Oct 1, 2026: "Scientific Industries signs CFO agreement and extends two others". Zachary Rovinsky signed an employment agreement as chief financial officer, and the agreements of Helena Santos and John A. Moore were extended through September 30, 2027. Source.
How can I follow SCIENTIFIC INDUSTRIES INC (SCND) news?
Press Follow on this page to add SCIENTIFIC INDUSTRIES INC to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming SCIENTIFIC INDUSTRIES INC so far, in Company Updates.
Investor discussion: SCIENTIFIC INDUSTRIES INC
Members talk about SCIENTIFIC INDUSTRIES INC (SCND). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Stock chart
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:SCND on TradingView.
Listing details
SCIENTIFIC INDUSTRIES INC is a public biotech or pharmaceutical company listed on OTC under the ticker SCND, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Company
SCIENTIFIC INDUSTRIES INC
Ticker
SCND
Listing
OTC
Country or territory
United States
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio